Clofazimine: History and Perspectives
The review analyses 47 publications that follow the pathway of clofazimine from its discovery to recognition as a Group B drug for treatment of multiple drug resistant tuberculosis. It describes its mechanism of action and effects on Mycobacterium tuberculosis, pharmacokinetics, and safety parameter...
| Published in: | Туберкулез и болезни лёгких |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2021-06-01
|
| Subjects: | |
| Online Access: | https://www.tibl-journal.com/jour/article/view/1541 |